Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkem Laboratories Limited Call Transcript 2025

Oct 28, 2025

61611_rns_2025-10-28_3343af01-4c64-43b1-a89c-5c7ad7794f3b.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [604 x 108] intentionally omitted <==

28[th] October, 2025

To,

The Corporate Relationship Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai 400 001.
Scrip Code: 539523
National Stock Exchange of India Limited
Exchange Plaza,
Bandra Kurla Complex,
Bandra East,
Mumbai 400 051.
Scrip Symbol: ALKEM

Sub: Intimation of Conference Call on Q2 and H1FY26 financial results

Dear Sir(s) / Madam,

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2 and H1FY26 financial results will be held on Thursday, November 13, 2025 at 04.30 p.m.

Please find attached herewith the conference call details.

Kindly take note of the same.

Sincerely, For Alkem Laboratories Limited

Digitally signed MANISH by MANISH NARANG NARANG Date: 2025.10.28 14:51:37 +05'30' Manish Narang

President – Legal, Company Secretary & Compliance Officer

==> picture [597 x 123] intentionally omitted <==

Invite for Q2FY26 & H1FY26 Conference Call at 4.30 pm IST, November 13, 2025

Mumbai, October 28, 2025: Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Thursday, November 13, 2025, from 4:30 pm to 5:30 pm IST to discuss its Q2 and H1FY26 financial results. The call will follow the announcement of the Company’s Q2 and H1FY26 financial results on Thursday, November 13, 2025.

Alkem Laboratories Ltd. will be represented on the call by:

Dr. Vikas Gupta – CEO Mr. Nitin Agrawal – CFO

Motilal Oswal Securities Ltd. will host the call.

Details of the conference call are as follows:

Time: 4:30 pm IST (GMT + 5:30) on Thursday, November 13, 2025.

Dial in Details:

India: +91 22 6280 1149 / +91 22 7115 8050

International Toll-Free

USA :1 866 746 2133 UK : 0 808 101 1573 Singapore : 800 101 2045 Hong Kong : 800 964 448

Express Join with Diamond Pass

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9888903&link SecurityString=4bcbdb3028

You are requested to dial in 10 minutes ahead of the scheduled start time.

[Purvi Shah / Isha Trivedi] Tushar Manudhane Investor Relations / Media Institutional Research Analyst - Healthcare Alkem Laboratories Ltd. Motilal Oswal Securities Ltd. Mobile: +91 84337 00890 / 98925 90003 Tel.: +91 22 6129 1536 / +91 82911 38039 Tel.: +91 22 3982 9999 Ext: 9447 E-mail: E-mail: [email protected]/ [email protected] [email protected]